SuperworthMedtronic profit margin MDT
Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.
- Net margin, 12 months
- 13.9%
- Operating margin, 12 months
- 18.1%
- Net margin on a year earlier
- +0.3 pts
- Peer median
- 14.9%
Over the twelve months to Jul 31, 2026, Medtronic kept 13.9% of its revenue as net profit, with an operating margin of 18.1% and a gross margin of 65.0%.
Five years earlier its net margin was 12.3%.
The median for 7 medical device stocks of a similar size is 14.9%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2026 | 13.2% | 17.8% | 65.0% |
| FY2025 | 13.9% | 17.8% | 65.3% |
| FY2024 | 11.4% | 15.9% | 65.3% |
| FY2023 | 12.0% | 17.6% | 65.7% |
| FY2022 | 15.9% | 18.2% | 68.0% |
| FY2021 | 12.0% | 14.9% | 65.2% |
| FY2020 | 16.6% | 16.6% | 67.4% |
| FY2019 | 15.2% | 20.5% | 70.0% |
| FY2018 | 10.4% | 22.2% | 69.7% |
| FY2017 | 13.6% | 17.9% | 68.7% |
| FY2016 | 12.3% | 18.4% | 68.3% |
| FY2015 | 13.2% | 18.6% | 68.9% |
| FY2014 | 18.0% | 23.5% | 74.5% |
| FY2013 | 20.9% | 27.2% | 75.1% |
| FY2012 | 22.4% | 28.8% | 76.0% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q1 FY27 | 13.9% | +0.3 pts | 18.1% | |
| Q4 FY26 | 13.2% | −0.7 pts | 17.8% | |
| Q3 FY26 | 13.0% | +0.2 pts | 17.0% | |
| Q2 FY26 | 13.7% | +0.7 pts | 17.9% | |
| Q1 FY26 | 13.6% | +1.6 pts | 17.9% | |
| Q4 FY25 | 13.9% | +2.5 pts | 17.8% | |
| Q3 FY25 | 12.8% | −0.2 pts | 16.8% | |
| Q2 FY25 | 13.0% | +0.2 pts | 16.4% | |
| Q1 FY25 | 12.1% | +0.6 pts | 15.8% | |
| Q4 FY24 | 11.4% | −0.7 pts | 15.9% | |
| Q3 FY24 | 13.0% | −0.2 pts | 17.5% | |
| Q2 FY24 | 12.8% | −1.2 pts | 17.4% |
Against its peers
Companies in Medical - Devices nearest Medtronic's size, closest first, today.
| Company | Profit margin |
|---|---|
| MDTMedtronic | 13.9% |
| SYKStryker | 14.4% |
| ABTAbbott Laboratories | n/m |
| BSXBoston Scientific | 17.5% |
| EWEdwards Lifesciences | 15.4% |
| GEHCGE HealthCare Technologies | 9.3% |
| DXCMDexCom | 20.1% |
| ZBHZimmer Biomet | 9.5% |
| Peer median | 14.9% |
Where Medtronic ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Medtronic
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.